| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Bakhshi Sandeep | Chief Executive Officer, Director | ICICI BANK TOWERS, BANDRA-KURLA COMPLEX, MUMBAI, INDIA | /s/ Vivek Ranjan, as Attorney-in-fact | 18 Mar 2026 | 0002119583 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | IBN | Equity Shares, par value Rs. 2 per share | 876,300 | 18 Mar 2026 | Direct | ||||||
| holding | IBN | Equity Shares, par value Rs. 2 per share | 2,293 | 18 Mar 2026 | Held through Mona Bakhshi, spouse of Sandeep Bakhshi | ||||||
| holding | IBN | Equity Shares, par value Rs. 2 per share | 40,112 | 18 Mar 2026 | Held through Shivam Bakhshi, son of Sandeep Bakhshi | ||||||
| holding | IBN | Equity Shares, par value Rs. 2 per share | 30,412 | 18 Mar 2026 | Held through Esha Bakhshi, daughter of Sandeep Bakhshi | ||||||
| holding | IBN | Equity Shares, par value Rs. 2 per share | 30,206 | 18 Mar 2026 | Held through Minal Bakhshi, daughter of Sandeep Bakhshi | ||||||
| holding | IBN | Equity Shares, par value Rs. 2 per share | 10 | 18 Mar 2026 | Held through Ashwin Pradhan, son-in-law of Sandeep Bakhshi |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | IBN | Stock Option (Right to Buy) | 18 Mar 2026 | Equity Shares, par value Rs. 2 per share | 242,100 | $14.67 | Direct | F1, F2, F3 | ||||||
| holding | IBN | Stock Option (Right to Buy) | 18 Mar 2026 | Equity Shares, par value Rs. 2 per share | 254,100 | $12.04 | Direct | F2, F3, F4 | ||||||
| holding | IBN | Stock Option (Right to Buy) | 18 Mar 2026 | Equity Shares, par value Rs. 2 per share | 299,100 | $9.67 | Direct | F2, F3, F5 | ||||||
| holding | IBN | Stock Option (Right to Buy) | 18 Mar 2026 | Equity Shares, par value Rs. 2 per share | 317,800 | $8.09 | Direct | F2, F3, F6 | ||||||
| holding | IBN | Stock Option (Right to Buy) | 18 Mar 2026 | Equity Shares, par value Rs. 2 per share | 394,850 | $6.16 | Direct | F2, F3, F7 | ||||||
| holding | IBN | Stock Option (Right to Buy) | 18 Mar 2026 | Equity Shares, par value Rs. 2 per share | 427,350 | $3.65 | Direct | F2, F3, F8 | ||||||
| holding | IBN | Stock Option (Right to Buy) | 18 Mar 2026 | Equity Shares, par value Rs. 2 per share | 244,200 | $4.35 | Direct | F2, F3, F9 | ||||||
| holding | IBN | Stock Option (Right to Buy) | 18 Mar 2026 | Equity Shares, par value Rs. 2 per share | 673,750 | $2.71 | Direct | F2, F3, F10 | ||||||
| holding | IBN | Stock Option (Right to Buy) | 18 Mar 2026 | Equity Shares, par value Rs. 2 per share | 913,000 | $2.40 | Direct | F2, F3, F11 | ||||||
| holding | IBN | Stock Option (Right to Buy) | 18 Mar 2026 | Equity Shares, par value Rs. 2 per share | 1,100,000 | $2.64 | Direct | F2, F3, F12 | ||||||
| holding | IBN | Stock Option (Right to Buy) | 18 Mar 2026 | Equity Shares, par value Rs. 2 per share | 673,750 | $3.03 | Direct | F2, F3, F13 | ||||||
| holding | IBN | Stock Option (Right to Buy) | 18 Mar 2026 | Equity Shares, par value Rs. 2 per share | 220,000 | $2.56 | Direct | F2, F3, F14 |
| Id | Content |
|---|---|
| F1 | A total of 242,100 stock options granted on April 17, 2025 and vesting in three tranches: (i) 72,630 vesting on April 17, 2026 and expiring on April 16, 2031, (ii) 72,630 vesting on April 17, 2027 and expiring on April 16, 2032, and (iii) 96,840 vesting on April 17, 2028 and expiring on April 16, 2033. |
| F2 | Each stock option represents the contingent right to apply for one Equity Share. |
| F3 | The exercise prices of the stock options are denominated in Rupee and translated for convenience only into USD at the rate of INR92.47 to US$1.00, the exchange rate set forth int he H.10 statistical release of the Federal Reserve Board on March 13, 2026. |
| F4 | A total of 254,100 stock options granted on April 26, 2024 and vesting in three tranches: (i) 76,230 vested on April 26, 2025 and expiring on April 25, 2030, (ii) 76,230 vesting on April 26, 2026 and lapsing on April 25, 2031, and (iii) 101,640 vesting on April 26, 2027 and expiring on April 25, 2032. |
| F5 | A total of 299,100 stock options granted on April 21, 2023 and vesting in three tranches: (i) 89,730 vested on April 21, 2024 and expiring on April 20, 2029, (ii) 89,730 vested on April 21, 2025 and expiring on April 20, 2030, and (iii) 119,640 vesting on April 21, 2026 and expiring on April 20, 2031. |
| F6 | A total of 317,800 stock options granted on April 23, 2022 and vesting in three tranches: (i) 95,340 vested on April 23, 2023 and expiring on April 22, 2028, (ii) 95,340 vested on April 23, 2024 and expiring on April 22, 2029, and (iii) 127,120 vested on April 23, 2025 and expiring on April 22, 2030. |
| F7 | A total of 394,850 stock options granted on April 24, 2021 and vesting in three tranches: (i) 118,455 vested on April 24, 2022 and expiring on April 23, 2027, (ii) 118,455 vested on April 24, 2023 and expiring on April 23, 2028, and (iii) 157,940 vested on April 24, 2024 and expiring on April 23, 2029. |
| F8 | A total of 610,500 stock options granted on May 9, 2020 and vesting in three tranches: (i) 183,150 vested on May 9, 2021 and expiring on May 8, 2026, which have been fully exercised by the Reporting Person prior to expiration, (ii) 183,150 vested on May 9, 2022 and expiring on May 8, 2027, and (iii) 244,200 vested on May 9, 2023 and expiring on May 8, 2028. |
| F9 | A total of 610,500 stock options granted on May 6, 2019 and vesting in three tranches: (i) 183,150 vested on May 6, 2020 and expired on May 5, 2025, which have been fully exercised by the Reporting Person prior to expiration, (ii) 183,150 vested on May 6, 2021 and expiring on May 5, 2026, which have been fully exercised by the Reporting Person prior to expiration, and (iii) 244,200 vested on May 6, 2022 and expiring on May 5, 2027. |
| F10 | A total of 673,750 stock options granted on May 3, 2017 and vesting in three tranches: (i) 202,125 vested on May 3, 2018 and expiring on May 2, 2028, (ii) 202,125 vested on May 3, 2019 and expiring on May 2, 2029, and (iii) 269,500 vested on May 3, 2020 and expiring on May 2, 2030. |
| F11 | A total of 913,000 stock options granted on April 28, 2016 and vesting in three tranches: (i) 273,900 vested on April 28, 2017 and expiring on April 27, 2027, (ii) 273,900 vested on April 28, 2018 and expiring on April 27, 2028, and (iii) 365,200 vested on April 28, 2019 and expiring on April 27, 2029. |
| F12 | A total of 1,100,000 stock options granted on September 16, 2015 and vesting in two tranches: (i) 550,000 vested on April 30, 2018 and expiring on April 29, 2028 and (ii) 550,000 vested on April 30, 2019 and expiring on April 29, 2029. |
| F13 | A total of 962,500 stock options granted on April 27, 2015 and vesting in three tranches: (i) 288,750 vested on April 27, 2016 and expiring on April 26, 2026, which have been fully exercised by the Reporting Person prior to expiration, (ii) 288,750 vested on April 27, 2017 and expiring on April 26, 2027, and (iii) 385,000 vested on April 27, 2018 and expiring on April 26, 2028. |
| F14 | A total of 962,500 stock options granted on April 25, 2014 and vesting in three tranches: (i) 288,750 vested on April 25, 2015 and expired on April 24, 2025, which have been fully exercised by the Reporting Person prior to expiration, (ii) 288,750 vested on April 25, 2016 and expiring on April 24, 2026, which have been fully exercised by the Reporting Person prior to expiration, and (iii) 385,000 vested on April 25, 2017 and expiring on April 24, 2027, 165,000 of which have been exercised by the Reporting Person prior to expiration. |
Exhibit 24.1. See power of attorney attached